Anti-tumor necrosis factor inhibitor therapy-induced dermatomyositis and fasciitis

Journal of Rheumatology

Volumn 39, Issue 1, 2012, Pages 192-194

  Riolo, Giovanna ^a   Towheed, Tanveer E ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CD45 ANTIGEN; CD68 ANTIGEN; INFLIXIMAB; METHOTREXATE; PREDNISONE; RHEUMATOID FACTOR; SMALL NUCLEAR RIBONUCLEOPROTEIN; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARTHRALGIA; AUTOIMMUNE MYOSITIS; CASE REPORT; CROHN DISEASE; DERMATOMYOSITIS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DRUG DOSE INCREASE; DRUG INDUCED MYOSITIS; DRUG WITHDRAWAL; EDEMA; ERYTHEMA; FACE EDEMA; HUMAN; JOINT SWELLING; LABORATORY TEST; LEG EDEMA; LETTER; LIMB WEAKNESS; MALE; MORNING STIFFNESS; MUSCLE BIOPSY; MUSCLE FATIGUE; MUSCLE NECROSIS; MYALGIA; MYOSITIS; NECK EDEMA; NECROTIZING FASCIITIS; NIGHT SWEAT; POLYMYOSITIS; PRIORITY JOURNAL; PYOMYOSITIS; SIDE EFFECT; WEIGHT REDUCTION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; CROHN DISEASE; DERMATOMYOSITIS; EDEMA; FASCIITIS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855397150     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. Yoshida K, Kurosaka D, Joh K, Matsushima S, Takahashi E, Hirai K, et al. Fasciitis as a common lesion of dermatomyositis, demonstrated early after disease onset by en block biopsy combined with magnetic resonance imaging. Arthritis and Rheum 2010;62:3751-9.
2. Rafailidis PI, Kapaskellis A, Falagas ME. Periorbital and facial swelling due to dermatomyositis. CMAJ 2007;176:1580-1. (Pubitemid 46868605)
3. Ramos-Casals M, Brito-Zerón P, Soto MJ, Cuadrado MJ, Khamashta MA. Autoimmune diseases induced by TNF-targeted therapies. Best Pract Res Clin Rheumatol 2008;22:847-61.
4. Brunasso AM, Massone C. Is dermatomyositis in patients with rheumatoid arthritis induced by anti-TNF alpha therapy? Clin Rheumatol 2011;30:439-40.
5. Nagashima T, Minota S. Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment? Clin Rheumatol 2010;29:819-20.
6. Ishikawa Y, Yukawa N, Ohmura K, Hosono Y, Mura Y, Kawabata D, et al. Etanercept-induced anti-Jo-1 antibody positive polymyositis in a patient with rheumatoid arthritis: A case report and review of the literature. Clin Rheumatol 2010;29:563-6.
7. Brunasso AM, Scocco GL, Massone C. Dermatomyositis during adalimumab therapy for rheumatoid arthritis. J Rheumatol 2010;37:1549-50.
8. Klein R, Rosenbach M, Kim EJ, Kim B, Werth VP, Dunham J. Tumor necrosis factor inhibitor-associated dermatomyositis. Arch Dermatol 2010;146:780-4.
9. Ramos-Casals M, Roberto-Perez-Alvarez, Diaz-Lagares C, Cuadrado MJ, Khamashta MA; BIOGEAS Study Group. Autoimmune diseases induced by biological agents: A double-edged sword? Autoimmun Rev 2010;9:188-93.